Richard P. Thompson

Former President & Chief Executive Officer at ReShape Weightloss, Inc.

Richard P. Thompson

Richard P. Thompson

Former President & Chief Executive Officer at ReShape Weightloss, Inc.

Overview
Career Highlights

LifeScan Scotland Ltd.
ReShape Medical, Inc.
ReShape Weightloss, Inc.

RelSci Relationships

397

Number of Boards

7

Birthday

1952

Age

69

Relationships
RelSci Relationships are individuals Richard P. Thompson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at GlySens, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at GlySens, Inc.

Relationship likelihood: Strong

General Partner at U.S. Venture Partners

Relationship likelihood: Strong

Professional at Farapulse, Inc.

Relationship likelihood: Strong

Venture Partner at Delos Advisors Ltd.

Relationship likelihood: Strong

Venture Partner at SV Health Investors LLP

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Aradigm Corp.

Relationship likelihood: Strong

Co-Founder at ReShape Medical, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at ABK Biomedical, Inc.

Relationship likelihood: Strong

Senior Advisor at Apercen Partners LLC

Relationship likelihood: Strong

Paths to Richard P. Thompson
Potential Connections via
Relationship Science
You
Richard P. Thompson
Former President & Chief Executive Officer at ReShape Weightloss, Inc.
Education
Undergraduate Degree

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

MBA Business

California Lutheran University's dedicated, accomplished faculty works with small classes of undergraduate and graduate students who are open-minded—about ideas, about people, and about faith—and are seeking to grow as individuals.

Career History
President, Chief Executive Officer & Director
2011 - 2016

ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA.

President & Chief Executive Officer
2011 - 2016

ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA.

President, Chief Executive Officer & Director
2005 - 2011

Luminous Medical is developing an Automated Blood Glucose Monitor (ABGM) that addresses the rapidly growing clinical demand for better, safer glycemic control in the intensive care unit (ICU), Operating Room (OR) and Intermediate Care Units. Compelling clinical evidence has demonstrated significant morbidity and mortality benefits from normalizing glucose levels in hyperglycemic patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with time consuming and inadequate manual glucose monitoring methods.

Transactions
Details Hidden

ReShape Medical, Inc. raised money in a private placement transaction

Details Hidden

ReShape Medical, Inc. raised money in a private placement transaction

Details Hidden

ReShape Medical, Inc. raised money in a private placement transaction

Investments
Details Hidden

Luminous Medical is developing an Automated Blood Glucose Monitor (ABGM) that addresses the rapidly growing clinical demand for better, safer glycemic control in the intensive care unit (ICU), Operating Room (OR) and Intermediate Care Units. Compelling clinical evidence has demonstrated significant morbidity and mortality benefits from normalizing glucose levels in hyperglycemic patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with time consuming and inadequate manual glucose monitoring methods.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard P. Thompson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard P. Thompson's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard P. Thompson.